Company profilePharmaceutical#421 of 1,318 in Pakistan✓ No DRAP alerts

SIMZ Pharmaceuticals (Pvt) Ltd.

Pharmaceutical company · 38 brands · 40 molecules

Ranked #18 of 213 companies in Other Beta-Lactam, Cephalosporins & Penems

38 registered products 16 pharmaceutical brands 40 distinct molecules 0 DRAP alerts

Company overview

38
registered products
16
pharmaceutical brands
40
distinct molecules
12
therapeutic classes
0
DRAP alerts

SIMZ Pharmaceuticals (Pvt) Ltd. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 38 product registrations across 40 distinct molecules. Its portfolio is concentrated in Other Beta-Lactam, Cephalosporins & Penems and Macrolides, Lincosamides And Streptogramins. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by SIMZ

4 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Anti-Infectives 1

Top molecules by brand count

Azithromycin2 brands
Zinc2 brands
Ebastine2 brands
Cefaclor1 brand
Cefotaxime1 brand
Metformin1 brand

Therapeutic classes

Other Beta-Lactam, Cephalosporins & Penems · 10Macrolides, Lincosamides And Streptogramins · 4Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 4Quinolone Antibacterials · 4Antianemic, Iron Preparations · 3Antihistamines For Systemic Use · 3Other Mineral Supplements · 2Antiinflammatory And Antirheumatic Products · 2Drugs For Obstructive Airway Diseases, Systemic · 2Antimycotics Systemic Use · 1Blood Glucose Lowering Drugs, Excluding Insulin · 1Anti-Infectives · 1

Conditions treated

General Infections · 1Non-Sedative Agents · 1

Price band (DRAP official ceilings)

Registered products priced by source
Servaid4 products · Rs 50.02 – Rs 316.2
Median across source: Rs 173.3

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

SHROOQ PHARMACEUTICALS18 shared molecules
BIO LABS (PVT) LTD.14 shared molecules
FYNK PHARMACEUTICALS14 shared molecules
NEUTRO PHARMA (PVT) LTD.14 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

SHROOQ PHARMACEUTICALS holds 22 molecules not in this portfolio
AcitretinAcyclovirAcyclovir Inf/OralCefiximeCiprofloxacinDiclofenac
SIZA INTERNATIONAL (PVT) LTD. holds 85 molecules not in this portfolio
AcyclovirAlbendazoleAlbuterolAllopurinolAllopurinol TabAmikacin
GETZ PHARMA PAKISTAN (PVT) LTD. holds 272 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAcyclovirAdrenalineAlbendazole

Get the full profile for SIMZ

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.